Takeda (Japan)
In research, Takeda (Japan) stands highest in Health Sciences (#1,225 of 9,902 worldwide), Medicine (#1,133 of 8,541 worldwide) and Life Sciences (#1,163 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Hematology, Genetics and Statistics and Probability (Hematology is 16.8× its share of world research).
- World rank, 2022-now
- #2,434 of 22,385 · #2,090 all time
- Rank in Japan
- #45 of 924
- Research works
- 10k ▼ 7% vs 2018-21
- Citations
- 244k 23.6 per fractional work
- Top-10% rate
- 11.0% all institutions 10.0%
- vs its own fields
- 1.00× 1.00× is exactly expected
- Open access
- 49% world 40%
- International
- 21% world 18%
What is Takeda (Japan) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #1,225 of 9,902 | 13.1% | 588 | #835 | |
| MedicineField | #1,133 of 8,541 | 13.0% | 553 | #787 | |
| Life SciencesDomain | #1,163 of 6,403 | 10.1% | 335 | #1121 | |
| Biochemistry, Genetics and Molecular BiologyField | #994 of 2,964 | 7.8% | 187 | #1182 | |
| Molecular BiologySubfield | #894 of 1,880 | 7.5% | 106 | #1051 | |
| Physical SciencesDomain | #5,786 of 10,670 | 6.8% | 218 | #5903 | |
| Immunology and MicrobiologyField | #425 of 681 | 10.8% | 60 | #568 | |
| OncologySubfield | #526 of 755 | 9.4% | 65 | #596 | |
| EngineeringField | #4,316 of 5,901 | 6.6% | 76 | #2977 | |
| HematologySubfield | #164 of 190 | 10.7% | 62 | - |
Each strip is that field's whole ranked pool, with the notch where Takeda (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#835 #1,225
- Medicine#787 #1,133
- Life Sciences#1,121 #1,163
- Biochemistry, Genetics and Molecular Biology#1,182 #994
- Molecular Biology#1,051 #894
- Physical Sciences#5,903 #5,786
- Immunology and Microbiology#568 #425
- Oncology#596 #526
- Engineering#2,977 #4,316
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Takeda (Japan) work in?
In 2022-now, 47% of research at Takeda (Japan) is in Health Sciences, 28% in Life Sciences. Its largest fields are Medicine (44%), Biochemistry, Genetics and Molecular Biology (15%), Engineering (6%). It does 2.1× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences63747.2%
- Medicine60044.4%
- Health Professions221.6%
- Nursing110.8%
- Veterinary30.2%
- Dentistry10.0%
- Life Sciences37327.6%
- Physical Sciences23617.5%
- Engineering806.0%
- Chemistry332.4%
- Mathematics292.1%
- Computer Science282.1%
- Materials Science251.9%
- Environmental Science211.5%
- Physics and Astronomy70.5%
- Chemical Engineering60.4%
- Energy40.3%
- Earth and Planetary Sciences30.2%
- Social Sciences1047.7%
- Economics, Econometrics and Finance463.4%
- Psychology272.0%
- Social Sciences131.0%
- Decision Sciences90.7%
- Business, Management and Accounting60.4%
- Arts and Humanities30.2%
What does Takeda (Japan) specialise in?
Where its research is concentrated relative to its size: Hematology takes 16.8× the share of its output that it takes of world research.
- HematologySubfield · 68.9 works17×
- GeneticsSubfield · 33.4 works9.0×
- Statistics and ProbabilitySubfield · 24.7 works8.6×
- ImmunologySubfield · 65.0 works7.0×
- Immunology and MicrobiologyField · 68.5 works5.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.0×. Every wedge is a field page.
All 26 fields, with their numbers
- Immunology and Microbiology5.04×68 works
- Pharmacology, Toxicology and Pharmaceutics3.80×18 works
- Biochemistry, Genetics and Molecular Biology2.88×208 works
- Neuroscience2.82×62 works
- Medicine2.31×600 works
- Mathematics1.81×29 works
- Veterinary1.73×3 works
- Nursing1.66×11 works
- Economics, Econometrics and Finance1.59×46 works
- Chemistry1.56×33 works
- Chemical Engineering1.24×6 works
- Decision Sciences0.72×9 works
- Psychology0.65×27 works
- Health Professions0.62×22 works
- Materials Science0.54×25 works
- Engineering0.40×80 works
- Energy0.32×4 works
- Environmental Science0.31×21 works
- Agricultural and Biological Sciences0.27×18 works
- Computer Science0.26×28 works
- Physics and Astronomy0.23×7 works
- Earth and Planetary Sciences0.16×3 works
- Business, Management and Accounting0.13×6 works
- Dentistry0.09×1 works
- Social Sciences0.08×13 works
- Arts and Humanities0.07×3 works
- Immunology and Microbiology 5.0×
- Pharmacology, Toxicology and Pharmaceutics 3.8×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Neuroscience 2.8×
- Medicine 2.3×
- Mathematics 1.8×
- Veterinary 1.7×
- Nursing 1.7×
- Economics, Econometrics and Finance 1.6×
- Chemistry 1.6×
- Chemical Engineering 1.2×
- Decision Sciences 0.7×
- Psychology 0.7×
- Health Professions 0.6×
- Materials Science 0.5×
- Engineering 0.4×
- Energy 0.3×
- Environmental Science 0.3×
- Agricultural and Biological Sciences 0.3×
- Computer Science 0.3×
- Physics and Astronomy 0.2×
- Earth and Planetary Sciences 0.2×
- Business, Management and Accounting 0.1×
- Dentistry 0.1×
- Social Sciences 0.1×
- Arts and Humanities 0.1×
Who are the top researchers at Takeda (Japan)?
Ranked on the quality score, Shoji Fukusumi, Haruo Onda and Yoshiaki Kassai lead among researchers whose main affiliation is Takeda (Japan).
- 1
Shoji Fukusumi
Japan · #183,730 worldwide 9.9k citations · 42 works
- 2
Haruo Onda
Japan · #256,601 worldwide 12k citations · 94 works
- 3
Yoshiaki Kassai
Japan · #270,684 worldwide 2.4k citations · 44 works
- 4
Tadahiro Nambu
Japan · #283,659 worldwide 5.5k citations · 53 works
- 5
Jason K. Yano
Japan · #296,783 worldwide 5.1k citations · 118 works
- 6
Keiko Koga
Japan · #347,478 worldwide 1.5k citations · 23 works
- 7
Yuuichi Sakurai
Japan · #359,802 worldwide 1.3k citations · 20 works
- 8
Tsutomu Kurokawa
Japan · #383,183 worldwide 9.6k citations · 69 works
- 9
Nobuo Cho
Japan · #384,028 worldwide 1.7k citations · 43 works
- 10
Masaki Hosoya
Japan · #435,681 worldwide 10k citations · 49 works
Which keywords describe research at Takeda (Japan)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Genetics, Pathogenesis, Inflammation, Inflammatory Bowel Disease, Monoclonal Antibodies, Thrombosis and Vaccine Development.
- Vector Control
- Hemophilia
- Recombinant Factor VIIa
- Inhibitors
- Efficacy
- Glycosylation
- Sleep
- Health Utility Measures
- Vaccine
- Immunogenicity
- Biopharmaceuticals
- Therapies
- Immunology
- Chemotherapy
- Circadian Rhythms
- Diagnosis
- Clinical Trials
- Quality of Life
- Pathogenesis
- Inflammation
- Epidemiology
- Genetics
- Inflammatory Bowel Disease
- Monoclonal Antibodies
- Thrombosis
- Vaccine Development
- Gene Therapy
- Targeted Therapy
- Crohn's Disease
- Ulcerative Colitis
- Economic Evaluation
- Memory
- Cost-effectiveness Analysis
- Consolidation
- Lymphoma
- Hemostasis
- Prophylaxis
- Parkinson's Disease
- Factor VIII
- Therapeutic Antibodies
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology130▲ 2.4×87 topics
- Inflammation75▲ 2.6×67 topics
- Genetics56▲ 5.9×20 topics
- Pathogenesis51▲ 7.3×18 topics
- Inflammatory Bowel Disease44▲ 27×5 topics
- Quality of Life41▲ 2.1×29 topics
- Monoclonal Antibodies39▲ 32×3 topics
- Clinical Trials38▲ 4.2×14 topics
- Thrombosis38▲ 10×7 topics
- Diagnosis35▲ 2.8×30 topics
- Vaccine Development34▲ 9.9×8 topics
- Circadian Rhythms34▲ 23×2 topics
- Gene Therapy34▲ 13×4 topics
- Chemotherapy32▲ 3.3×21 topics
- Targeted Therapy31▲ 10×5 topics
- Immunology29▲ 20×2 topics
- Crohn's Disease29▲ 27×2 topics
- Therapies28▲ 44×1 topic
- Ulcerative Colitis28▲ 44×1 topic
- Biopharmaceuticals27▲ 39×3 topics
- Economic Evaluation26▲ 17×2 topics
- Immunogenicity26▲ 46×2 topics
- Memory26▲ 7.9×4 topics
- Vaccine26▲ 4.8×11 topics
- Cost-effectiveness Analysis26▲ 24×1 topic
- Health Utility Measures26▲ 24×1 topic
- Consolidation25▲ 47×1 topic
- Sleep25▲ 47×1 topic
- Lymphoma25▲ 12×4 topics
- Glycosylation24▲ 16×3 topics
- Hemostasis24▲ 18×3 topics
- Efficacy23▲ 21×2 topics
- Prophylaxis23▲ 13×4 topics
- Inhibitors23▲ 41×4 topics
- Parkinson's Disease23▲ 6.7×8 topics
- Recombinant Factor VIIa22▲ 34×2 topics
- Factor VIII21▲ 107×1 topic
- Hemophilia21▲ 107×1 topic
- Therapeutic Antibodies21▲ 23×2 topics
- Vector Control21▲ 13×4 topics
Which research topics does Takeda (Japan) publish most on?
By volume in 2022-now: Inflammatory Bowel Disease, Health Systems, Economic Evaluations, Quality of Life, Sleep and Wakefulness Research and Hemophilia Treatment and Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Inflammatory Bowel Disease Genetics 28 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 26 works
- 3 Sleep and Wakefulness Research Cognitive Neuroscience 25 works
- 4 Hemophilia Treatment and Research Hematology 21 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 18 works
- 6 Biosimilars and Bioanalytical Methods Immunology 18 works
- 7 CAR-T cell therapy research Oncology 17 works
- 8 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 17 works
- 9 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 16 works
- 10 Platelet Disorders and Treatments Hematology 15 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Takeda (Japan)'s research output changed?
Output in 2022-2025 was 7% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Takeda (Japan) as a percentage of every work published that year, 0.0058% in 2024.
Fractional works of Takeda (Japan) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.6% in 1993.
Other research institutions in Osaka
- The University of Osaka
- Osaka City University
- Kindai University
- National Cerebral and Cardiovascular Center
- Kansai Medical University
- Osaka International Cancer Institute
- Osaka Institute of Technology
- Osaka Research Institute of Industrial Science and Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Takeda (Japan). Posts are plain text and can be reported.
